USCA RIA’s Guardant Health GH Stock Holding History

USCA RIA’s Portfolio GH Stock Details GH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	–	Sell	-2,700	Closed	-$211K	–	436
2019 Q4	$211K	Buy	+2,700	New	+$195K	0.02%	436

Other funds holding GH

SIAU

SB Investment Advisers (UK) London, United Kingdom $7.66B AUM 20.12% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return

ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return

Coatue Management New York $48.6B AUM 94.27% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return

USCA RIA's GH Position: Q1 2020 in Review

USCA RIA sold out of Guardant Health (GH) in Q1 2020, closing a stake of 2,700 shares — an estimated $211K sold.

USCA RIA first reported a position in GH in Q4 2019 and held it in 1 quarter. The position peaked at $211K in Q4 2019. 288 funds tracked by Wall St. Rank hold GH as of Q1 2020.

USCA RIA reported no remaining Guardant Health position as of Q1 2020 after selling out during the quarter.
USCA RIA sold 2,700 Guardant Health shares in Q1 2020, an estimated $211K.
USCA RIA first reported a position in Guardant Health in Q4 2019 and held it in 1 quarter.
USCA RIA's Guardant Health position peaked at $211K in Q4 2019.
288 funds tracked by Wall St. Rank held Guardant Health as of Q1 2020.

Based on USCA RIA's 13F filing for Q1 2020, filed 13 Apr 2020.